Medicare Enrolled
Dr. Amir Kaykha, M.D.
Cardiovascular Disease · San Jose, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kaykha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kaykha?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kaykha
Dr. Amir Kaykha is a cardiovascular disease specialist in San Jose, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Kaykha performed 12,185 Medicare services across 3,330 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kaykha received a total of $1,173 from 11 pharmaceutical and/or device companies across 27 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kaykha is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 5% volume in CA
$1,173 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,185
Medicare services
Top 5% in CA for cardiovascular disease
3,330
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~677 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Adenosine injection, 1 mg Administration of a 1 mg dose of adenosine medication. This code is specifically for adenosine and excludes adenosine phosphate compounds. |
7,077 | $0 | $7 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,037 | $13 | $57 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
891 | $114 | $261 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 405 | $417 | $654 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
287 | $197 | $545 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
204 | $73 | $235 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
203 | $40 | $150 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
203 | $1 | $80 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
202 | $1,607 | $3,000 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
177 | $28 | $100 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
155 | $24 | $73 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
125 | $26 | $83 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
125 | $110 | $239 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
124 | $22 | $105 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
124 | $954 | $1,450 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
104 | $24 | $75 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
104 | $36 | $50 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
98 | $192 | $450 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
63 | $77 | $178 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
63 | $155 | $465 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
52 | $46 | $91 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
50 | $141 | $350 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
46 | $192 | $538 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
39 | $11 | $136 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
38 | $78 | $144 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
33 | $33 | $135 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
32 | $91 | $238 |
| Ultrasound of leg arteries at rest and after exercise This test uses sound waves to create images of the blood vessels in the legs while the patient is resting and after physical activity to assess blood flow. |
32 | $169 | $458 |
| Cardiac catheterization | 29 | $213 | $949 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $151 | $349 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
13 | $81 | $450 |
| Balloon dilation of single coronary artery or branch A procedure to widen a single coronary artery or its branch using a balloon catheter to restore blood flow. |
12 | $224 | $850 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
11 | $13 | $120 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.1% high complexity
65.6% medium
27.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,173
Total received (2018-2024)
Avg $168/year across 7 years
Bottom 35% in CA for cardiovascular disease
11
Companies
27
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,173 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$456
2023
$84
2022
$85
2021
$54
2020
$79
2019
$119
2018
$297
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ShockWave Medical, Inc
$199
Edwards Lifesciences Corporation
$153
Baxter Healthcare
$46
Philips North America LLC
$36
Abbott Laboratories
$22
Top 3 companies account for 87.1% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$291
ABIOMED
$267
ShockWave Medical, Inc
$199
Edwards Lifesciences Corporation
$153
Inari Medical, Inc.
$84
Baxter Healthcare
$46
Philips North America LLC
$36
Novartis Pharmaceuticals Corporation
$35
Boston Scientific Corporation
$30
Abbott Laboratories
$22
Medtronic Vascular, Inc.
$11
Top 3 companies account for 64.5% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · DIAMONDBACK CORONARY · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ENTRESTO · FLOWTRIEVER CATHETER · GENERAL BRADY · Hillrom - Carnation Ambulatory Monitor · Impella · LATITUDE · Repatha · Reveal LINQ · S · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
207
Per 100K population
10.9
County median income
$159,674
Nearest hospital
SANTA CLARA VALLEY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kaykha is a mixed practice specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kaykha experienced with adenosine injection, 1 mg?
Based on Medicare claims data, Dr. Kaykha performed 7,077 adenosine injection, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kaykha receive payments from pharmaceutical companies?
Yes. Dr. Kaykha received a total of $1,173 from 11 companies across 27 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kaykha's costs compare to other cardiologists in San Jose?
Dr. Kaykha's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kaykha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in San Jose
Browse cardiologists in San Jose ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
ShockWave Medical, Inc Payments to Doctors
See all physicians who received payments from ShockWave Medical, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology